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ABSTRACT 
Diabetes is one of the leading chronic diseases affecting Australians and its prevalence continues to rise. Diabetes is therefore 
becoming a serious challenge for both the quality of healthcare and expenditure in the Australian healthcare system.  The 
goal of this study is to investigate the development and application of a pervasive wireless technology solution to facilitate 
the effective management of diabetic patients, using the context of the care of women with gestational diabetes, a form of 
diabetes that affects up to 8% of pregnant women as a test case.  Integral to the success of this solution is the unique software 
technology developed by INET to enable mobile phones to facilitate superior diabetes self-management.   
Keywords  
Australia, healthcare, diabetes, gestational diabetes self-management, wireless, pervasive technologies 
INTRODUCTION 
Diabetes mellitus [diabetes] is one of the leading chronic diseases affecting Australians and its prevalence continues to rise.  
The total number of diabetes patients worldwide is estimated to rise to 366 million in 2030 from 171 million in 2000 (Wild, 
Roglic, Green, Sicree and King, 2004). With increasingly growing prevalence which includes an estimated 275 Australians 
developing diabetes daily (DiabetesAustralia, 2008), Australia is expected to be a significant contributor to this projected 
trend.  An estimated 700,000 Australians, representing approximately 3.6% of the population, were diagnosed with diabetes 
in 2004-05.  Between 1989-90 and 2004-05 the proportion of Australians diagnosed with this disease more than doubled 
from 1.3% to 3.3%.  Additionally, between 2000-01 and 2004-05, Australian diabetes hospitalisations increased by 35% from 
1,932 to 2,608 hospitalisations per 100,000 people (AIHW, 2008).  For every person diagnosed with diabetes, it is estimated 
that there is another who has yet to be diagnosed, which doubles the number of diabetes sufferers (DiabetesAustralia, 2008).  
Diabetes is, thus, one of the fastest growing chronic diseases in Australia (AIHW, 2008, Catanzariti, Faulks and Waters, 
2007, Chittleborough, Grant, Phillips and Taylor, 2007).  
Diabetes and its complications incur significant costs for the health system in Australia, including costs incurred by carers, 
government, and the entire health system (DiabCostAustralia, 2002).  In 2004-05 direct healthcare expenditure on diabetes 
was A$907 million, which constituted approximately 2% of the allocatable recurrent health expenditure in that year (AIHW, 
2008).  Further costs include societal costs that represent productivity losses for both patients and their carers 
(DiabCostAustralia, 2002).  
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Recognizing the need to have a solution that can enable the ubiquitous monitoring of diabetes patients while also 
continuously educating them, the goal of this paper is to investigate the development and application of DiaMonD – a 
diabetes monitoring device.  Powered by pervasive technology software developed by INET, DiaMonD is a wireless enabled 
mobile phone that can facilitate superior diabetes self-management in the Australian setting.  The realization of this goal can 
contribute by establishing a benchmark for theoretical and empirical testing.  To achieve this goal, first we provide a general 
background on the Australian health scene and critically review existing research and then, we elaborate the proposed 
pervasive mobile technology solution and the anticipated barriers and facilitators in the Australian setting.   
CURRENT AUSTRALIAN HEALTH SCENE  
Both healthcare professionals and diabetes patients require quality information if disease conditions are to be effectively 
managed.  There are several deficiencies in the information provided by the existing system for monitoring diabetes in 
Australia (Dixon and Webbie, 2006, Sprivulis, Walker, Johnston, Pan, Adler-Milstein, Middleton and Bates, 2007, Swerissen 
and Taylor, 2008).  First, data collected in hospitals are episode-based rather than patient-based, making it difficult to 
determine statistics concerning individual admissions, re-admissions, and treatment patterns.  Second, there is a lack of data 
on incidence and prevalence by diabetes type, so as to assess reliably the magnitude of the problem.  Third, the accuracy of 
recording data in administrative data sets, such as hospital morbidity, mortality and general practice data, is uncertain.  
Finally, clinical management information is derived from uncoordinated and fragmented data collections that are not 
representative of the entire population of diabetes patients, making comparison, analysis and trend identification difficult.  
These deficiencies are the result of the current health system set up.  Based on fee-for-service episodic doctor-patient 
consultation, the current Australian healthcare system is well placed to handle short-term illnesses involving a limited range 
of interventions including their diagnosis and treatment (Hunt, 2007).  However, this system is comprised of a mixture of 
fragmented private and public healthcare subsystems that provide both healthcare funding and delivery.  Largely 
uncoordinated, these subsystems are deemed to be unsuitable for the treatment of long-term chronic diseases, including 
diabetes (Dixon and Webbie, 2006, Sprivulis et al., 2007).  In particular, the chronic and multisystem nature of diabetes and 
its complications requires teams of various health professionals and long-term support to help sufferers make effective 
healthy lifestyle changes and constantly maintain them (Hunt, 2007).  
CURRENT DIABETES SELF-MANAGEMENT RESEARCH 
As there is no cure for diabetes, non-medical approaches are used jointly with medical approaches, so that patients with the 
disease can have a life which is as normal as possible.  Such non-medical approaches require effective and ongoing lifestyle 
management, together with meticulous attention and monitoring by both patients and healthcare professionals (Britt, Miller, 
Charles, Pan, Valenti, Henderson, Bayram, O'Halloran and Knox, 2007).  Particularly, to be successful, patients need to be 
both informed and active in their treatment regimen (AIHW, 2008, AIHW, 2007).  These aims can be achieved by effective 
self-management, which is a non-medical approach and which constitutes the focus of this paper.  
Self-management is important as it empowers diabetes patients while acknowledging their central role and responsibility for 
managing their healthcare (ICIC, 2008).  Active participation of diabetes patients in self-management is a key strategy for 
managing their condition and reaching improved treatment outcomes (Colagiuri, Colagiuri and Ward, 1998, Poulton, 1999, 
Rasmussen, Wellard and Nankervis, 2001, Wellard, Rennie and King, 2008).  However, self-management is constantly time-
consuming and requires significant self-discipline (Russell, Churl Suh and Safford, 2005) and support strategies including 
assessment, goal-setting, action-planning, problem-solving and follow-up (ICIC, 2008).  Moreover, because effective self-
management may require patient interaction with various healthcare professionals, including diabetes physicians, general 
practitioners, diabetes educators, dieticians, and community nurses (Knuiman, Welborn and Bartholomew, 1996), difficulties 
can arise when diabetes patients encounter problems ranging from making appointments to needing to travel to many 
locations (Van Eyk and Baum, 2002, Wellard et al., 2008, Zigbor and Songer, 2001).  Given both the importance and 
complexity of applying self-management effectively for both prevention and early detection of diabetes, there are increasing 
calls for further research to facilitate self-management (Wellard et al., 2008).  
Solutions for supporting self-management (Chau and Turner, 2006, Rudi and Celler, 2006) have not always been effective, 
due to the reality that “patients did not learn how to do it [apply the solutions] or they did not understand the rules which 
were explained to them, or they were not sure enough of their knowledge, uncertainty entailing indecision” (Reach, Zerrouki, 
Leclercq and d'Ivernois, 2005).  On the other hand, computer-assisted telemedicine can help people with diabetes improve 
both their self-management (Balas, Krishna, Kretschmer, Cheek, Lobach and Boren, 2004) and their relationship with 
healthcare professionals (Bodenheimer, Lorig, Holman and Grumbach, 2002, Downer, Meara, Da Costa and Sethuraman, 
2006).  
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THE CASE OF GESTATIONAL DIABETES 
Gestational diabetes (GDM) is a common form of diabetes that presents in pregnancy, sometimes with symptoms but often 
diagnosed in otherwise normal women on a routine screening test.  Some women, particularly those in whom the diagnosis of 
GDM is made early in pregnancy, may have pre-existing undiagnosed diabetes.  In Australia and New Zealand, universal 
screening for GDM is recommended by the Australasian Diabetes in Pregnancy Society (ADIPS) (Hoffman, Nola, Wilson, 
Oats and Simmons, 1998), although the uptake of the recommendation is rather variable (Rumbold and Crowther, 2001). It is 
estimated that in Australia, 3-6% of pregnant women will develop GDM at around 24-28 weeks gestation, with a smaller 
number earlier and later in pregnancy.  An Australian study of 210 pregnant women found that screening for GDM had an 
adverse impact on women's perceptions of their own health (Rumbold and Crowther, 2002). GDM is more common in older 
women, in those with a family history of diabetes, in those who are overweight and in those of non-Caucasian heritage.  
Maternal complications of GDM include polyhydramnios and premature labour, and pre-eclampsia (Hoffman et al., 1998).  It 
recurs in subsequent pregnancy in 30-80% of women, the incidence varying with ethnicity, being lower in Caucasian women 
(Kim, Berger and Chamany, 2007).   
Treatment of women with GDM aims to control maternal, and therefore fetal, hyperglycaemia and the associated tendency to 
fetal hyperinsulinaemia, which is at the root of the fetal complications (Metzger et al., 2008). After many years of uncertainty 
as to the value of such treatment in GDM, two trials have now shown benefit for both mother and offspring for antenatal 
initiation of lifestyle modification and glucose monitoring, coupled with insulin therapy as necessary (Crowther, Hiller, 
Moss, McPhee, Jeffries and Robinson, 2005, Landon et al., 2009).  Antenatal treatment of screen detected mild GDM was 
also associated with improved health status for women during the antenatal period and at 3 months after birth, with less 
postnatal depression (Crowther et al., 2005). 
Critical to the GDM and to successful pregnancy outcome is careful and systematic monitoring of maternal glycaemia and 
appropriate adjustment of lifestyle, dietary and pharmacological therapy in the light of the results.  Therefore, in this paper, 
we investigate the development and application of DiaMonD as a pervasive mobile technology solution to facilitate superior 
diabetes self-management in the case of women with GDM.  
 
Component Description 
Organisation of Health 
System 
Leadership in chronic disease management (CDM) 
Goals for CDM 
Improvement strategy for CDM 
Incentives and regulations for CDM 
Benefits 
Self-management support Assessment and documentation of needs and activities 
Addressing concerns of patients 
Effective behaviour change interventions 
Decision Support Evidence-based guidelines 
Involvement of specialists in improving primary care 
Providing education for CDM 
Informing patients about guidelines 
Delivery System design Practice team functioning 
Practice team leadership 
Appointment system 
Follow-up 
Planned visits for CDM 
Continuity of Care 
Clinical Information 
Systems 
Registry 
Reminders to providers 
Feedback 
Information about relevant subgroups of patients needing services 
Patient treatment plans 
Community Linkages for patients to resources 
Partnerships with community organizations 
Policy and plan development 
Table 1. Components of Chronic Care Model (Rachlis, 2006) 
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THE DEVELOPMENT OF A PERVASIVE MOBILE TECHNOLOGY SOLUTION 
We propose DiaMonD – diabetes monitoring device – as a solution which incorporates software that facilitates the ubiquitous 
monitoring of an individual’s diabetes, thereby, contributing to diabetes self-management. The solution is grounded in trying 
to support key components of a chronic disease care model (Table 1). INET International Inc.’s research (Goldberg, 2002a, 
Goldberg, 2002d, Goldberg, 2002b, Goldberg, 2002e, Goldberg, 2002c, Wickramasinghe and Goldberg, 2004, 
Wickramasinghe and Goldberg, 2003) starts with a 30-day e-business acceleration project in collaboration with many key 
players in hospitals, such as clinicians, medical units, administration, and I.T. departments.  Together, they follow a rigorous 
procedure that refocuses the traditional 1-5-year SDLC into concurrent 30-day projects to accelerate healthcare delivery 
improvements.  At completion, an e-business acceleration project delivers a scope document to develop a handheld 
technology application (HTA) proof-of-concept specific to the unique needs of a particular environment.  The proof-of-
concept is a virtual lab case scenario which operates within a mobile Internet (wireless) environment by working with 
hospitals and technology vendors.  The final step is the collection of additional data with clinical HTA trials consisting of 
two-week hospital evaluations. 
The INET web-based model (figure 1) provides the necessary components to enable the delivery framework to be positioned 
in the best possible manner so it can indeed facilitate enacting the key components of the chronic disease model successfully 
(table 1). The model is positioned to suit the complex nature of healthcare environments by iteratively, systematically, and 
rigorously incorporating lessons learnt data to healthcare processes for ensuring superior healthcare delivery.  This manner 
not only maximizes the value of past data and organisational learning, but it also makes processes amendable as complex 
needs and requirements evolve. 
It is important to note that in the INET web-based model the three key areas of risk, namely, people, processes and 
technology, are minimised through the use of pervasive technology, which we believe is a unique benefit of the INET 
solution.  Specifically, since the proposed solution is an application that is compatible with any mobile phone or wireless 
device (e.g. a PDA), data transfers occur between patients and providers on a well-vetted model.  Therefore, the learning 
curve for patients may be minimal as they are likely to be in possession of mobile devices. 
 
Figure 1. INET web-based model 
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What makes this model unique and most beneficial is its focus on enabling and supporting all areas necessary for the 
actualization of ICT initiatives in healthcare.  By design, the model identifies the inputs necessary to bring an innovative 
chronic disease management solution to market.  These solutions are developed and implemented through a physician-led 
mobile e-health project.  This project is the heart of the model that bridges the needs and requirements of many different 
players into a final (output) deliverable, a “Wireless Healthcare Program”.  To accomplish this, the model is continually 
updated to identify, select and prioritize the ICT project inputs that will: 
 Accelerate healthcare system enhancements and achieve rapid healthcare benefits. The model identifies key healthcare 
system inputs with the four Ps, namely, 1) People that deliver healthcare, 2) Process to define the current healthcare 
delivery tasks, 3) Platform used in the healthcare technology infrastructure, and 4) Protection of patient data.   
 Close the timing gaps between information research studies and their application in healthcare operational settings.  
 Shorten the time cycle to fund an ICT project and receive an adequate return on the investment. 
These 4 Ps were chosen after discussions with various healthcare professionals as to the areas they believed were critical 
inputs for any model. These categories are mutually exclusive and collectively exhaustive based on the views of experts 
consulted. In applying the INET-based solution to any particular context of diabetes sufferers it is necessary to consider the 
scope or extent of the diabetes problems in this context, the specific contextual features such as demographics as well as 
current processes in place to treat patients so that the application will be tailored to this population hence “localize” is an 
important aspect in the delivery frame work. In addition, it is important to understand the make-up of the care team or field 
and finally results need to be evaluated.  
Thus, the delivery framework helps to make the solution applicable to any context of diabetes patients which is an essential 
consideration given that diabetes cuts across all areas of the community. Together the components of the model will help in 
actualizing physician-led solution for the management of chronic diseases in general and of diabetes in particular.  To 
successfully implement the INET web-based model described above, it was necessary to have an appropriate methodology.  
Based on this need, the adaptive mapping to realization methodology (AMR) was developed (figure 2).  The idea of the 
methodology was to apply a systematic rigorous set of predetermined protocols to each business case and then to map the 
post-prior results back to the model.  In this way, it was possible to compare and contrast both a priori and post priori 
findings.  From such a comparison, first a diagnosis of the current state was made, then prescriptions were derived for the 
next business case.  Hence, each pilot study incorporated the lessons learnt from the previous one and the model was adapted 
in real time. 
By applying the tools and techniques of today’s knowledge economy as presented in the intelligence continuum (IC), it is 
possible to make the AMR methodology into a very powerful knowledge-based systems development model.  The IC was 
developed by Wickramasinghe and Schaffer (2006) to enable the application of tools and technologies of the knowledge 
economy to be applied to healthcare processes in a systematic and rigorous fashion, thereby ensuring superior healthcare 
delivery.  The collection of key tools, techniques and processes that make up the IC include, but are not limited to, data 
mining, business intelligence/analytics and knowledge management (Wickramasinghe and Schaffer, 2006).  
Taken together, they represent a very powerful system for refining the raw data stored in data marts and/or data warehouses, 
thereby maximizing the value and utility of these data assets for any organization.  To maximize the value of the data 
generated through specific healthcare processes and then to use this to improve processes, IC techniques and tools must be 
applied in a systematic manner.  Once applied, the results become part of the data set that are subsequently reintroduced into 
the system and combined with other inputs of people, processes, and technology to develop an improvement continuum.  
Thus, the IC includes the generation of data, the analysis of these data to provide a “diagnosis”, and their reintroduction into 
the cycle as a “prescriptive” solution.  In this way, the IC is well suited to the dynamic and complex nature of healthcare 
environments and ensures that the future state is always built upon the extant knowledge-base of the preceding state.  
Through the incorporation of the IC with the AMR methodology we then have a knowledge-based systems development 
model that can be applied to any setting, not necessarily to chronic disease management.  The power of this model is that it 
brings best practices and the best available germane knowledge to each iteration and is both flexible and robust. 
Given the uniqueness of this approach it was necessary to develop this model from the beginning rather than look at other 
existing models. This was done by trying to understand key criteria from various stakeholders such as patients, healthcare 
professionals and hospital personnel and sort this information into a coherent whole. This was an iterative process which 
involved many and multiple discussions with the various stakeholders until all parties were agreed the model captured the 
essential elements as discussed in details in Goldberg (2002a-e) 
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Figure 2. AMR Methodology 
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To date directional data (Wickramasinghe and Goldberg, 2007) has already shown the benefits of this solution in various 
pilot studies in Canada. We believe that DiaMonD is a most beneficial solution given the huge and growing impact of 
diabetes. In particular, it is very cost effective for both patients and healthcare providers. We believe that as more pilot 
studies are conducted in different settings this will add data that will show the full and far reaching benefits of the proposed 
solution. What is certain is that current methods for treating patients with diabetes are unwieldy, generating significant costs, 
not especially patient-centric and doing little to stem the development of secondary complications thus a better solution is 
required. At this stage, the INET’s solution looks to be appropriate.  
Thus, DiaMonD represents a pervasive ICT enabled solution, which, while not exorbitantly expensive, can facilitate the 
superior monitoring of diabetes (figure 3).  The proposed solution enables patient empowerment by way of enhancing self-
management. This is a desirable objective because it allows patients to become more like partners with their clinicians in the 
management of their own healthcare (Opie, 1998, Radin, 2006) by enhancing the traditional clinical-patient interactions 
(Mirza, Norris and Stockdale, 2008).  However, because most work has focused on specific applications and proof-of-
concept studies, this paper would be incomplete without considering the critical success factors, including facilitators and 
barriers, that are expected to affect the ubiquitous adoption of the proposed solution in the Australian setting (Gururajan and 
Murugesan, 2005, Mirza et al., 2008).  
CONCLUSIONS  
Given the general global consensus that effective and efficient healthcare delivery will only occur through the judicious 
application of ICTs (FS, 2004, Kulkarni and Nathanson, 2005, Lacroix, 1999, Porter and Tiesberg, 2006, Wickramasinghe, 
2007), it is inevitable that, as we move into the second decade of the 21st century, the prevalence of ICTs to facilitate the 
delivery of value-driven healthcare will increase.  In such a climate, DiaMonD will be even more appropriate, not only 
because it utilises ICTs to provide superior healthcare delivery in the case of diabetic patients, but also because it is both 
simple to implement and use, and also cost effective both at the micro and macro levels.  These levels include individual 
patients, clinicians and organisations, including public and private healthcare providers.  
We set out to present a case for the need to embrace a pervasive technology solution for the superior monitoring of diabetes 
self-management for patients with diabetes in Australia, using gestational diabetes as an initial model.  We would contend  
that, as developed by INET, DiaMonD is a suitable wireless solution for many reasons, including that it is equally successful 
in controlling both type I and type II diabetes, is as effective irrespective of patient’s age, socio economic standing or location 
and has minimal risks and a very slight learning curve (if at all). Moreover, we strongly believe that, if DiaMonD and its 
underlying model were to be incorporated into the Australian context, the growing segment of the population suffering from 
diabetes would have a convenient, cost effective and superior means of monitoring, and thereby controlling, their diabetes, 
while in turn enjoying a better quality of life.  
DiaMonD facilitates governments, associations, pharmaceutical firms, researchers, healthcare professionals and other 
healthcare stakeholders that are looking for improved and measurable outcomes among patients suffering from diabetes.  
Specific benefits range from decreasing diabetes-related complications to reducing the economic burden on the health 
system.  We realise that further research is required to test DiaMonD in the Australian healthcare setting including testing of 
aspects, such as perceived ease of use, perceived usefulness, etc.  We conclude by warning that, if a pervasive technology 
solution is not sought for the monitoring and support of diabetes self-management, then this chronic disease, which is already 
at pandemic level, will continue to be a very costly burden for both the healthcare sector and the community at large.  
REFERENCES 
1. AIHW (2008) Diabetes: Australian Facts 2008, Canberra, Australian Institute of Health and Welfare. 
2. AIHW (2007) National Indicators for Monitoring Diabetes: Report of the Diabetes Indicators Review Subcommittee of 
the National Diabetes Data Working Group: AIHW cat. no. CVD 38, Canberra, AIHW. 
3. Balas, E. A., Krishna, S., Kretschmer, R. A., Cheek, T. R., Lobach, D. F., and Boren, S. A. (2004) Computerized 
knowledge management in diabetes care, Medical Care, 42, 6, 610-621. 
4. Bodenheimer, T., Lorig, K., Holman, H., and Grumbach, K. (2002) Patient self-management of chronic disease in 
primary care, Journal of American Medical Association (JAMA), 288, 19, 2469-2475. 
5. Britt, H., Miller, G. C., Charles, J., Pan, Y., Valenti, L., Henderson, J., Bayram, C., O'Halloran, J., and Knox, S. (2007) 
General Practice Activity in Australia 2005-06, Cat. no. GEP 16, Canberra, AIHW. 
6. Catanzariti, L., Faulks, K., and Waters, A.-M. (2007) National Diabetes Register: Statistical Profile 1999-2005, AIHW 
cat. no. CVD 39, Canberra, AIHW. 
Wickramasinghe et al.  A Pervasive Technology Solution for Diabetes 
Proceedings of the Sixteenth Americas Conference on Information Systems, Lima, Peru, August 12-15, 2010. 8 
7. Chau, S. and Turner, P. (2006) Utilisation of mobile handheld devices for care management at an Australian aged care 
facility, Electronic Commerce Research and Applications, 5305-312. 
8. Chittleborough, C. R., Grant, J. F., Phillips, P. J., and Taylor, A. W. (2007) The increasing prevalence of diabetes in 
South Australia: the relationship with population ageing and obesity, Public Health, 12192-99. 
9. Colagiuri, S., Colagiuri, R., and Ward, J. (1998) National Diabetes Strategy and Implementation Plan, Canberra, 
Diabetes Australia. 
10. Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., and Robinson, J. S. (2005) The effect of 
treatment of gestational diabetes mellitus on pregnancy outcomes, The New England Journal of Medicine, 3522477-
2486. 
11. DiabCostAustralia (2002) Assessing the Burden of Type 2 Diabetes in Australia, Adelaide, DiabCost Australia. 
12. DiabetesAustralia (2008) Diabetes in Australia.   
13. Dixon, T. and Webbie, K. (2006) The National System for Monitoring Diabetes in Australia (AIHW Cat. No. CVD 32), 
Canberra, Australian Institute of Health and Wealfare. 
14. Downer, S. R., Meara, J. G., Da Costa, A. C., and Sethuraman, K. (2006) SMS text messaging improves outpatient 
attendance, Australian Health Review, 30, 3, 389-396. 
15. FS (2004) Frost and Sullivan Country Industry Forecast, May 11, 2004, Available: http://www.news-
medical.net/print_article.asp?id=1405, European Union Healthcare Industry. 
16. Goldberg, S. (2002a) Building the Evidence for a standardized Mobile Internet (wireless) Environment in Ontario, 
Canada, January Update, Internal INET Documentation, Ontario, Canada, INET. 
17. Goldberg, S. (2002d) HTA Presentation Rendering Component Summary, Internal INET documentation, Ontario, 
Canada, INET. 
18. Goldberg, S. (2002b) HTA Presentational Selection and Aggregation Component Summary. Internal INET 
Documentation, Ontario, Canada, INET. 
19. Goldberg, S. (2002e) HTA Quality Assurance Component Summary, Internal INET documentation, Ontario, Canada, 
INET. 
20. Goldberg, S. (2002c) Wireless POC Device Component Summary, Internal INET documentation, Ontario, Canada, 
INET. 
21. Gururajan, R. and Murugesan, S. (2005) Wireless solutions developed for the Australian healthcare: A review, in 
Proceedings of 4th International Conference on Mobile Business, Sydney, Australia, IEEE 
22. Hoffman, L., Nola, C., Wilson, J. D., Oats, J., J. N., and Simmons, D. (1998) Gestational diabetes mellitus -- 
management guidelines, The Medical Journal of Australia, 16, 993-97. 
23. Hunt, D. (2007) Urgent health system reform needed to tackle disease epidemic, says head of new University of 
Melbourne centre. [WWW] 2007  [cited 2008 25 November]; Available from: 
http://uninews.unimelb.edu.au/view.php?articleID=4615. 
24. ICIC (2008) Improving Chronic Illness Care: The Chronic Care Model.    
25. Kim, C., Berger, D. K., and Chamany, S. (2007) Recurrence of gestational diabetes mellitus: a systematic review, 
Diabetes Care, 30, 1314-1319. 
26. Knuiman, M. W., Welborn, T. A., and Bartholomew, H. C. (1996) Self-reported health and use of health services: a 
comparison of diabetic and nondiabetic persons from a national sample, Australian and New Zealand Journal of Public 
Health, 20, 3, 241-247. 
27. Kulkarni, R. and Nathanson, L. A. (2005) Medicine Informatics in Medicine. Available: 
http://www.emedicine.com/emerg/topic879.htm. 
28. Lacroix, A. (1999) International concerted action on collaboration in telemedicine: G8sub-project 4, Sted. Health 
Technol. Inform., 64, 12-19. 
29. Landon, M. B. et al. (2009) A multicenter, randomized trial of treatment for mild gestational diabetes, The New England 
Journal of Medicine, 361, 1339-1348. 
30. Metzger, et al. (2008) Hyperglycemia and adverse pregnancy outcomes, The New England Journal of Medicine, 358, 
19, 1191-2002. 
31. Mirza, F., Norris, T., and Stockdale, R. (2008) Mobile technologies and the holistic management of chronic diseases, 
Health Informatics Journal, 14, 4, 309-321. 
32. Opie, A. (1998) Nobody's asked me for my view: users' empowerment by multidisciplinary health teams, Qualitative 
Health Research, 18, 188-206. 
33. Porter, M. and Tiesberg, E. (2006) Re-defining health care delivery, Boston, Harvard Business Press. 
34. Poulton, B. C. (1999) User involvement in identifying health needs and shaping and evaluating services: is it being 
raised?, Journal of Advanced Nursing, 30, 6, 1289-1296. 
Wickramasinghe et al.  A Pervasive Technology Solution for Diabetes 
Proceedings of the Sixteenth Americas Conference on Information Systems, Lima, Peru, August 12-15, 2010. 9 
35. Rachlis, M. Key to sustainable healthcare system.  2006  [cited 2008 21 June]; Available from: 
http://www.improveinchroniccare.org. 
36. Radin, P. (2006) To me, it's my life: medical communication, trust, and activism in cyberspace, Social Science & 
Medicine, 6, 591-601. 
37. Rasmussen, B., Wellard, S., and Nankervis, A. (2001) Consumer issues in navigating health care services for type I 
diabetes, Journal of Clinical Nursing, 10, 628-634. 
38. Reach, G., Zerrouki, D., Leclercq, D., and d'Ivernois, J. F. (2005) Adjusting insulin doses: from knowledge to decision, 
Patient Education and Counseling, 56, 1, 98-103. 
39. Rudi, R. and Celler, B. G. (2006) Design and implementation of expert-telemedicine system for diabetes management at 
home, in Proceedings of International Conference on Biomedical and Pharmaceutical Enginering 2006 (ICBPE2006), 
11-14 December 2006, Singapore, IEEE 
40. Rumbold, A. R. and Crowther, C. A. (2001) Guideline use for gestational diabetes mellitus and current screening, 
diagnostic and management practices in Australian hospitals, The Australian and New Zealand Journal of Obstetrics 
and Gynaecology, 41, 86-90. 
41. Rumbold, A. R. and Crowther, C. A. (2002) Women's experiences of being screened for gestational diabetes mellitus, 
The Australian and New Zealand Journal of Obstetrics and Gynaecology, 42, 131-137. 
42. Russell, L. B., Churl Suh, D., and Safford, M. M. (2005) Time requirements for diabetes management: too much for 
many?, The Journal of Family Practice, 54, 1, 52-56. 
43. Sprivulis, P., Walker, J., Johnston, D., Pan, E., Adler-Milstein, J., Middleton, B., and Bates, D. W. (2007) The economic 
benefits of health information exchange interoperability, Australian Health Review, 31, 4, 531-539. 
44. Swerissen, H. and Taylor, M. J. (2008) Reforming funding for chronic illness: Medicare-CDM, Australian Health 
Review, 32, 1, 76-84. 
45. Van Eyk, H. and Baum, F. (2002) Learning about interagency collaboration: Trialling collaborative projects between 
hospitals and community health services, Health and Social Care in the Community, 10, 4, 262-269. 
46. Wellard, S. J., Rennie, S., and King, R. (2008) Perceptions of people with type 2 diabetes about self-management and 
the efficiency of community based services, Contemporary Nurse, 29, 2, 218-226. 
47. Wickramasinghe, N. (2007) Fostering knowledge assets in healthcare with the KMI model, International Journal of 
Management and Enterprise Development, 4, 1, 52-65. 
48. Wickramasinghe, N. and Goldberg, S. (2004) How M=EC2 in healthcare, International Journal of Mobile 
Communications, 2, 2, 140-156. 
49. Wickramasinghe, N. and Goldberg, S. (2003) The wireless panacea for healthcare, in Proceedings of 36th Hawaii 
International Conference on System Sciences, Hawaii, 6-10 January, IEEE 
50. Wickramasinghe, N. and Schaffer, J. (2006) Creating knowledge driven healthcare processes with the intelligence 
continuum, International Journal of Electronic Healthcare, 2, 2, 164-174. 
51. Wickramasinghe, N., & Goldberg, S. (2007). Adaptive mapping to realisation methodology (AMR) to facilitate mobile 
initiatives in healthcare. International Journal of Mobile Communications, 5, 3, 300-318 
52. Wild, S., Roglic, G., Green, A., Sicree, R., and King, H. (2004) Global prevalence of diabetes: estimates for the year 
2000 and projections for 2030, Diabetes Care, 271047-1053. 
53. Zigbor, J. C. and Songer, T. J. (2001) External barriers to diabetes care: addressing personal and health systems issues, 
Diabetes Spectrum, 14, 23-28. 
 
 
 
 
